CN104311518B - A kind of preparation method of 6-methyl scutellarin genin - Google Patents
A kind of preparation method of 6-methyl scutellarin genin Download PDFInfo
- Publication number
- CN104311518B CN104311518B CN201410660948.XA CN201410660948A CN104311518B CN 104311518 B CN104311518 B CN 104311518B CN 201410660948 A CN201410660948 A CN 201410660948A CN 104311518 B CN104311518 B CN 104311518B
- Authority
- CN
- China
- Prior art keywords
- scutellarin
- flavone
- reaction
- benzyloxy
- acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
- C07D311/26—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3
- C07D311/28—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 2 only
- C07D311/30—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 2 only not hydrogenated in the hetero ring, e.g. flavones
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyrane Compounds (AREA)
Abstract
The present invention relates to the field of chemical synthesis, it is specifically related to the preparation of Chinese traditional medicine molecule scutellarin active metabolite, scutellarin hydrolyzation of glucose aldehydic acid molecule under strong acid effect is obtained 4 ', 5, 6, 7 kaempferols, 4 ', 5, 6, 7 kaempferols and bromobenzyl react in the presence of acid binding agent, generate 5, 6 dihydroxy 4 ', 7 benzyloxy flavone, 5 hydroxyl 6 methoxyl groups 4 ' are generated the most in the basic conditions with iodomethane reaction, 7 benzyloxy flavone, last 5 hydroxyl 6 methoxyl groups 4 ', 7 benzyloxy flavone catalytic hydrogenation debenzylation in the presence of palladium carbon obtains 6 methyl scutellarin genin.Step of the present invention is simple, easy purification, mild condition, low cost, and overall yield of reaction is more than 70%, and the product purity of synthesis is high, more than 99.0%, is suitable for technology and produces.
Description
Technical field
The present invention relates to the field of chemical synthesis, specifically, the present invention relates to scutellarin active metabolism molecule 6-first
The synthesis of base scutellarin genin.
Background technology
6-methyl scutellarin genin is natural product scutellarin active metabolism molecule, has the structure of formula (1).
Breviscapine is the flavonoid active ingredient extracted from natural plants Herba Erigerontis, has breviscapine, oil lamp second
Element etc., predominantly scutellarin (content is more than 95%) (Chen Yiyue, Wang Shengtao, Zeng Wenshan, Zhu Yinghong, Fu Yong
Prunus mume (sieb.) sieb.et zucc., Jiang Tao. the breviscapine relexation to rat aorta flesh ring. new Chinese medicine and clinical pharmacology .1994,5 (2),
15-19).Last century, Breviscapine from the seventies began to be applied to clinic, and research shows that breviscapine has
Have increase blood flow, improve microcirculation, expansion blood vessel, reduce blood viscosity, blood fat reducing, fibrinolysis enhancing, antithrombotic,
Antiplatelet aggregation etc. act on, and have at aspects such as treatment cardiovascular and cerebrovascular disease, rheumatic arthritis and apoplexy sequela
Significantly curative effect.
The main component scutellarin of breviscapine is easy to metabolism (Ge Qinghua, Zhou Zhen, Zhi Xiaojin, Ma Li in vivo
Beautiful, Chen Xiuhua. breviscapine pharmacokinetics in dog body and absolute bioavailability research. Chinese Medicine industry is miscellaneous
Will, 2003,34 (12), 618-621) (Feng Fang, Shen Yulan. trace scutellarin SPE-HPLC in human plasma
The foundation of/MS/MS and pharmacokinetic studies. Chinese Pharmaceutical Journal .2006,41 (6), 457), one of them active metabolism
Thing is 6-methyl scutellarin genin.
Owing to 6-methyl scutellarin genin has pharmacologically active widely, explore its chemosynthesis and be significant.
Document (Min-Zhe Shen, Zhi-Hao Shi, Nian-Guang Li, Hao-Tang, Qian-Ping Shi, Yu-Ping
Tang,Jian-Ping Yang,Jin-Ao Duan.Efficient Synthesis of 6-O-methyl-scutellarein from
Scutellarin via Selective Methylation.Letters in Organic Chemistry,2013,10(10),
733-737.) protect 4 ' initially with diphenyl dichloromethane, 6,7 adjacent diphenol hydroxyls in 5,6,7-kaempferol structure
Base, the most again with benzyl protection 4 ' position phenolic hydroxyl group, after removing 6,7 diphenyl methylene protection groups, then protects with benzyl
Protecting 7 phenolic hydroxyl groups, the method reaction scheme is long, and purifies and separates difficulty, production efficiency is relatively low, and the cost of production is relatively
Height, and reaction temperature when protecting with diphenyl dichloromethane is 175 DEG C, is not suitable for synthesizing 6-methyl oil lamp in a large number
B prime aglycon.
Summary of the invention
Goal of the invention: the invention aims to solve the deficiencies in the prior art, it is provided that a kind of 6-methyl oil lamp second
The preparation method of element aglycon, the present invention synthesizes 6-methyl scutellarin genin, preparation with scutellarin for initiation material
Method step is few, and purification is convenient, low cost, and yield is high, and product purity is high, is suitable for industrialized production.
Technical scheme, in order to realize object above, the technical method that the present invention takes is:
The preparation method of the present invention is following reaction equation:
The preparation method of a kind of 6-methyl scutellarin genin that the present invention provides, specifically includes following steps:
A, it is initiation material by scutellarin, under the catalysis of acid, adds pyrohydrolysis, generate 4 ', 5,6,7-tetrahydroxys yellow
Ketone (compound 2);
B, by the 4 ' of above-mentioned generation, 5,6,7-kaempferol (compound 2) in the presence of acid binding agent with cylite or
Benzyl chloride generation nucleophilic substitution, generates 5,6-dihydroxy-4 ', 7-benzyloxy flavone (3);
C, by the 5,6-dihydroxy-4 of above-mentioned generation ', 7-benzyloxy flavone (3) in the presence of acid binding agent with iodomethane
Reaction, generates 5-hydroxyl-6-methoxyl group-4 ', 7-benzyloxy flavone (4);
D, by the 5-hydroxyl-6-methoxyl group-4 of above-mentioned generation ', 7-benzyloxy flavone (4) passes through in the presence of palladium carbon
Catalytic hydrogenation removing benzyl obtains 6-methyl scutellarin genin (compound 1).
Above-mentioned reaction a step reaction solvent selects concentration to be the ethanol of 95%.
Above-mentioned reaction a step use concentrated acid be the one in mineral acid such as concentrated sulphuric acid, concentrated hydrochloric acid, concentrated nitric acid or it
Mixture.
Above-mentioned reaction b or step c one or more organic solvent the most following react: DMF (N, N-bis-
Methylformamide), acetone, acetonitrile, ethanol, chloroform, ethyl acetate, further preferred DMF (N, N-diformazan
Base Methanamide) or acetone.
Above-mentioned reaction Step d reaction dissolvent is selected from oxolane, ethanol, methanol, ethyl acetate or N, N-dimethyl
The preferred potassium carbonate of Methanamide acid binding agent, potassium bicarbonate, sodium carbonate, sodium bicarbonate.
In above-mentioned reaction, a step reaction temperature preferably 50~140 DEG C, further preferred 70~120 DEG C, b step and
The reaction temperature of step c preferably 10~150 DEG C, further preferred 30~60 DEG C.
Step a, b and c reaction system are preferably pressed into protective gas nitrogen or argon.
Wherein preferred 0.05g/ml~0.1g/ml of scutellarin concentration in alcoholic solution in a step, inorganic acid alcohol is molten
The concentration of liquid preferably 3~8mol/L, further preferred scutellarin concentration 0.07g/ml in alcoholic solution, inorganic acid alcohol
Concentration 5mol/L of solution.
4 ', 5,6,7-kaempferols and cylite or preferred 1:2~1:3 of mol ratio of benzyl chloride in step b, further
Preferably 1:2.3;
In step c 5,6-dihydroxy-4 ', 7-benzyloxy flavone and preferred 1:1~1:2 of mol ratio of iodomethane, enter one
Walk preferred 1:1.3;
5-hydroxyl-6-methoxyl group-4 in step d ', 7-benzyloxy flavone and preferred 1:0.05~1:1 of weight ratio of palladium carbon,
Further preferably 1:0.1.
Beneficial effect: compared to the prior art, the present invention has the following advantages:
Compared to the prior art, reactions steps is simple for the present invention, and purification is convenient, and production efficiency is high, mild condition,
Overall yield of reaction is more than 70%, and low cost, the product purity of synthesis is high, more than 99.0%, is suitable for technology and produces.
Accompanying drawing explanation
Fig. 1 is the structural representation of 6-methyl scutellarin genin of the present invention.
Fig. 2 is the reacting flow chart of 6-methyl scutellarin genin preparation method of the present invention.
Detailed description of the invention
According to following embodiment, the present invention be may be better understood.But, as it will be easily appreciated by one skilled in the art that
Concrete material proportion, process conditions and result thereof described by embodiment are merely to illustrate the present invention, and should not
Also without limitation on the present invention described in detail in claims.
Embodiment 1
The preparation of 4 ', 5,6,7-kaempferol (2)
Scutellarin 50 is added in the 1000ml reaction bulb pouring pipe equipped with mechanical agitator, thermometer and nitrogen into
G, 3mol L-190% concentrated sulphuric acid ethanol solution 500mL, be passed through nitrogen displaced air, be heated to 120 DEG C,
Reaction 48h, reaction cools down after terminating, and reactant liquor is poured in 4L water, sucking filtration, and filter cake is washed to neutrality, 50 DEG C
It is dried.Filter cake obtains yellow solid 26.3g, yield 85.5% with the ethanol recrystallization repeatedly of 50%.
Structure elucidation is1H NMR(300MHz,DMSO-d6)δ:6.78(s,1H,C3-H),6.73(s,1H,C8-H),
6.92 (d, J=8.8Hz, 2H, C3′,C5′-H), 7.92 (d, J=8.8Hz, 2H, C2′,C6′-H),8.71(s,1H,C6-OH),
10.30(s,1H,C4′-OH),10.44(s,1H,C7-OH),12.79(s,1H,C5-OH).ESI-MS:m/z 285
[M-H]-。
5,6-dihydroxy-4 ', the preparation of 7-benzyloxy flavone (3)
84g compound 2 is added in equipped with the 1000ml reaction bulb of mechanical agitator, thermometer and nitrogen ingress pipe,
DMF500ml, K2CO3109g, bromobenzyl 80mL, be passed through nitrogen displaced air, after room temperature reaction 12h, instead
Answer liquid 2000ml ethyl acetate to extract, then wash, methacrylate layer with 1000ml saline wash, methacrylate layer without
Water Na2SO4Being dried, filter, filtrate concentrates, and concentrate obtains yellow solid 128 with the ethanol recrystallization repeatedly of 50%
G, yield 93%.
Structure elucidation is1H NMR(300MHz,DMSO-d6)δ13.11(s,1H,5-OH),10.82(s,1H,
6-OH), 8.04 (d, 2H, J=8.6Hz, 2 ', 6 '-H), 7.31-7.53 (m, 10H ,-Ph), 7.18 (d, 2H, J=8.6Hz,
3′,5′-H),6.87(s,1H,8-H),6.62(s,1H,3-H),5.23(s,2H,-OCH2),5.03(s,2H,-OCH2);
ESI-MS:m/z 465[M-H]-.
5-hydroxyl-6-methoxyl group-4 ', the preparation of 7-benzyloxy flavone (4)
84g compound is added in equipped with the 1000ml reaction bulb of mechanical agitator, thermometer and nitrogen ingress pipe
3, DMF 200ml, K2CO348g, iodomethane 14ml, be passed through nitrogen displaced air, after room temperature reaction 12h,
Reactant liquor 500ml ethyl acetate is extracted, and then washes, methacrylate layer
200 saline washings, methacrylate layer anhydrous Na2SO4Being dried, filter, filtrate concentrates, concentrate 50% ethanol
Recrystallization, finally obtains compound as yellow solid 81g, yield 94%.
Structure elucidation is:1H NMR(300MHz,DMSO-d6) δ 12.69 (s, 1H, 5-OH), 7.94 (d, 2H, J=
8.6Hz,2′,6′-H),7.44-7.54(m,4H,-Ph),7.32-7.42(m,6H,-Ph),7.00(s,1H,8-H),6.94(d,
2H, J=8.6Hz, 3 ', 5 '-H), 6.62 (s, 1H, 3-H), 5.28 (s, 2H ,-OCH2),4.95(s,2H,-OCH2),4.00
(s,3H,-OCH3);ESI-MS:m/z 481[M+H]+.
The preparation of 6-methyl scutellarin genin (compound 1)
Compound 5-hydroxyl-6-methoxyl group-4 is added in equipped with 1000ml mono-neck bottle of magnetic stirring apparatus ', 7-dibenzyl
Epoxide flavone (4) 100g, in the mixed solution of dehydrated alcohol 250ml and THF 250ml, is subsequently adding 10%
Pd/C 2g, is passed through hydrogen exchange air, room temperature reaction 8h, reacts after terminating, and reacting liquid filtering concentrates, dense
Contracting thing obtains yellow solid (compound 1) 60g, yield 96% with 50% ethyl alcohol recrystallization.
Structure elucidation:1H NMR(300MHz,DMSO-d6)δ12.76(s,1H,5-OH),10.72(s,1H,
7-OH), 10.19 (s, 1H, 4 '-OH), 7.87 (d, 2H, J=8.6Hz, 2 ', 6 '-H), 6.89 (d, 2H, J=8.6Hz,
3′,5′-H),7.11(s,1H,8-H),6.58(s,1H,3-H),3.72(s,3H,-OCH3);ESI-MS:m/z 299
[M-H]-.
Embodiment 2
The preparation of 4 ', 5,6,7-kaempferol (2)
Scutellarin 50 is added in the 1000ml reaction bulb pouring pipe equipped with mechanical agitator, thermometer and nitrogen into
G, 3mol L-190% concentrated sulphuric acid ethanol solution 500mL, be passed through nitrogen displaced air, be heated to 120 DEG C,
Reaction 48h, reaction cools down after terminating, and reactant liquor is poured in 4L water, sucking filtration, and filter cake is washed to neutrality, 50 DEG C
It is dried.Filter cake obtains yellow solid 26.3g, yield 85.5% with the ethanol recrystallization repeatedly of 50%.
Structure elucidation is1H NMR(300MHz,DMSO-d6)δ:6.78(s,1H,C3-H),6.73(s,1H,C8-H),
6.92 (d, J=8.8Hz, 2H, C3′,C5′-H), 7.92 (d, J=8.8Hz, 2H, C2′,C6′-H),8.71(s,1H,C6-OH),
10.30(s,1H,C4′-OH),10.44(s,1H,C7-OH),12.79(s,1H,C5-OH).ESI-MS:m/z 285
[M-H]-。
5,6-dihydroxy-4 ', the preparation of 7-benzyloxy flavone (3)
84g compound 2 is added in equipped with the 1000ml reaction bulb of mechanical agitator, thermometer and nitrogen ingress pipe,
Acetone 500ml, K2CO3109g, bromobenzyl 80mL, be passed through nitrogen displaced air, after back flow reaction 8h, instead
Answering liquid to filter, filtrate concentrates, and concentrate obtains yellow solid 124g, yield 90% with the ethanol recrystallization repeatedly of 50%.
5-hydroxyl-6-methoxyl group-4 ', the preparation of 7-benzyloxy flavone (4)
84g compound is added in equipped with the 1000ml reaction bulb of mechanical agitator, thermometer and nitrogen ingress pipe
3, acetone 200ml, K2CO348g, iodomethane 14ml, be passed through nitrogen displaced air, after back flow reaction 10h,
Reacting liquid filtering, filtrate concentrates, concentrate 50% ethyl alcohol recrystallization, finally obtains compound as yellow solid 79g,
Yield 92%.
The preparation of 6-methyl scutellarin genin (compound 1)
Compound 5-hydroxyl-6-methoxyl group-4 is added in equipped with 1000ml mono-neck bottle of magnetic stirring apparatus ', 7-dibenzyl
Epoxide flavone (4) 100g, dehydrated alcohol 500ml, be subsequently adding 10%Pd/C 2g, is passed through hydrogen exchange air,
Room temperature reaction 8h, after reaction terminates, reacting liquid filtering, concentrate, it is solid that concentrate obtains yellow with 50% ethyl alcohol recrystallization
Body ((compound 1)) 58g, yield 92%.
Structure elucidation:1H NMR(300MHz,DMSO-d6)δ12.76(s,1H,5-OH),10.72(s,1H,
7-OH), 10.19 (s, 1H, 4 '-OH), 7.87 (d, 2H, J=8.6Hz, 2 ', 6 '-H), 6.89 (d, 2H, J=8.6Hz,
3′,5′-H),7.11(s,1H,8-H),6.58(s,1H,3-H),3.72(s,3H,-OCH3);ESI-MS:m/z 299
[M-H]-.
Embodiment 3
The preparation of 4 ', 5,6,7-kaempferol (2)
Scutellarin 50 is added in the 1000ml reaction bulb pouring pipe equipped with mechanical agitator, thermometer and nitrogen into
G, 3mol L-190% concentrated sulphuric acid ethanol solution 500mL, be passed through nitrogen displaced air, be heated to 120 DEG C,
Reaction 48h, reaction cools down after terminating, and reactant liquor is poured in 4L water, sucking filtration, and filter cake is washed to neutrality, 50 DEG C
It is dried.Filter cake obtains yellow solid 26.3g, yield 85.5% with the ethanol recrystallization repeatedly of 50%.
Structure elucidation is1H NMR(300MHz,DMSO-d6)δ:6.78(s,1H,C3-H),6.73(s,1H,C8-H),
6.92 (d, J=8.8Hz, 2H, C3′,C5′-H), 7.92 (d, J=8.8Hz, 2H, C2′,C6′-H),8.71(s,1H,C6-OH),
10.30(s,1H,C4′-OH),10.44(s,1H,C7-OH),12.79(s,1H,C5-OH).ESI-MS:m/z 285
[M-H]-。
5,6-dihydroxy-4 ', the preparation of 7-benzyloxy flavone (3)
84g compound 2 is added in equipped with the 1000ml reaction bulb of mechanical agitator, thermometer and nitrogen ingress pipe,
Acetone 500ml, Na2CO384g, bromobenzyl 80mL, be passed through nitrogen displaced air, after back flow reaction 8h, instead
Answering liquid to filter, filtrate concentrates, and concentrate obtains yellow solid 126g, yield 92% with the ethanol recrystallization repeatedly of 50%.
5-hydroxyl-6-methoxyl group-4 ', the preparation of 7-benzyloxy flavone (4)
84g compound is added in equipped with the 1000ml reaction bulb of mechanical agitator, thermometer and nitrogen ingress pipe
3, acetone 200ml, Na2CO337g, iodomethane 14ml, be passed through nitrogen displaced air, back flow reaction 10h
After, reacting liquid filtering, filtrate concentrates, concentrate 50% ethyl alcohol recrystallization, finally obtains compound as yellow solid 80
G, yield 93%.
The preparation of 6-methyl scutellarin genin (compound 1)
Compound 5-hydroxyl-6-methoxyl group-4 is added in equipped with 1000ml mono-neck bottle of magnetic stirring apparatus ', 7-dibenzyl
Epoxide flavone (4) 100g, dehydrated alcohol 500ml, be subsequently adding 10%Pd/C 2g, is passed through hydrogen exchange air,
Room temperature reaction 8h, after reaction terminates, reacting liquid filtering, concentrate, it is solid that concentrate obtains yellow with 50% ethyl alcohol recrystallization
Body ((compound 1)) 58g, yield 92%.
Structure elucidation:1H NMR(300MHz,DMSO-d6)δ12.76(s,1H,5-OH),10.72(s,1H,
7-OH), 10.19 (s, 1H, 4 '-OH), 7.87 (d, 2H, J=8.6Hz, 2 ', 6 '-H), 6.89 (d, 2H, J=8.6Hz,
3′,5′-H),7.11(s,1H,8-H),6.58(s,1H,3-H),3.72(s,3H,-OCH3);ESI-MS:m/z 299
[M-H]-.
Embodiment of above only for technology design and the feature of the present invention are described, its object is to allow and is familiar with technique
People understand present invention and be carried out, can not limit the scope of the invention with this, all according to this
The equivalence that bright spirit is done changes or modifies, and all should contain within the scope of the present invention.
Claims (1)
1. the preparation method of a 6-methyl scutellarin genin, it is characterised in that comprise the following steps:
A, taking scutellarin hydrolysis occurs in presence of an acid, removing glucuronic acid generates 4 ', 5,6,7-
Kaempferol;
B, by 4 ', 5,6,7-kaempferol in the presence of acid binding agent with cylite or benzyl chloride generation nucleophilic displacement of fluorine
Reaction, generates generation 5,6-dihydroxy-4 ', 7-benzyloxy flavone;
C, by 5,6-dihydroxy-4 ', 7-benzyloxy flavone in the presence of acid binding agent with iodomethane reaction, generate
5-hydroxyl-6-methoxyl group-4 ', 7-benzyloxy flavone;
D, by 5-hydroxyl-6-methoxyl group-4 ', 7-benzyloxy flavone, catalytic hydrogenation debenzylation in the presence of palladium carbon
Obtain 6-methyl scutellarin genin;
Step a reaction dissolvent be volumetric concentration be the ethanol of 95%;
Acid used by step a is a kind of in sulphuric acid, hydrochloric acid, nitric acid or their mixture;Step a is reacted
Temperature is 70~120 DEG C;
Step b or step c reaction dissolvent be N,N-dimethylformamide, acetone, acetonitrile, ethanol, chloroform,
One or more in ethyl acetate;
The reaction temperature of step b or c is 30~60 DEG C;
Acid binding agent in step b is potassium carbonate, sodium carbonate, potassium bicarbonate or sodium bicarbonate;
Step d reaction dissolvent is oxolane, ethanol, methanol, ethyl acetate or N,N-dimethylformamide;
Step a, b, c reaction are passed through nitrogen or argon, step d is passed through hydrogen;
In step a, scutellarin concentration in alcoholic solution is 0.07g/ml, and the concentration of mineral acid alcoholic solution is
5mol/L;
In step b 4 ', 5,6,7-kaempferol is 1:2.3 with the mol ratio of cylite or benzyl chloride;
5,6-dihydroxy-4 in step c ', 7-benzyloxy flavone is 1:1.3 with the mol ratio of iodomethane;
5-hydroxyl-6-methoxyl group-4 in step d ', 7-benzyloxy flavone is 1:0.1 with the weight ratio of palladium carbon.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410660948.XA CN104311518B (en) | 2014-11-18 | 2014-11-18 | A kind of preparation method of 6-methyl scutellarin genin |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410660948.XA CN104311518B (en) | 2014-11-18 | 2014-11-18 | A kind of preparation method of 6-methyl scutellarin genin |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104311518A CN104311518A (en) | 2015-01-28 |
CN104311518B true CN104311518B (en) | 2016-07-13 |
Family
ID=52366861
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410660948.XA Expired - Fee Related CN104311518B (en) | 2014-11-18 | 2014-11-18 | A kind of preparation method of 6-methyl scutellarin genin |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104311518B (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111484538B (en) * | 2019-01-29 | 2023-02-10 | 复旦大学 | Preparation method of homoplantaginoside |
CN111484471A (en) * | 2019-01-29 | 2020-08-04 | 复旦大学 | Preparation method of hispidulin |
CN110028474A (en) * | 2019-04-24 | 2019-07-19 | 四川省中医药科学院 | A method of preparing flavone aglycone or isoflavone |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2007083263A1 (en) * | 2006-01-23 | 2007-07-26 | Firmenich Sa | Process to prepare flavones |
CN101891728B (en) * | 2010-05-20 | 2012-05-23 | 南京中医药大学 | Scutellarein derivative as well as preparation method and application thereof |
CN101824017B (en) * | 2010-05-20 | 2012-01-11 | 南京中医药大学 | Method for preparing scutellarin aglycone |
CN102702155B (en) * | 2012-06-15 | 2014-05-07 | 南京中医药大学 | Scutellarin aglycone methylate product based on in-vivo metabolic mechanism as well as preparation method and application of scutellarin aglycone methylate product |
-
2014
- 2014-11-18 CN CN201410660948.XA patent/CN104311518B/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CN104311518A (en) | 2015-01-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104311518B (en) | A kind of preparation method of 6-methyl scutellarin genin | |
CN105237503B (en) | A kind of method for preparing baicalein | |
CN106188062A (en) | Replace the preparation method of Buddhist nun according to Shandong, replace intermediate and the preparation method of intermediate of Buddhist nun according to Shandong | |
CN102471302A (en) | Preparation process of dronedarone and its salts | |
CN102153600B (en) | The preparation method of 2-deoxidation-L-ribose | |
CN106946880A (en) | A kind of method for preparing Rui Boxini intermediates | |
CN103351291B (en) | It is a kind of that natural phlorizin is semi-synthetic prepares Phloretin technique | |
CN110407841A (en) | A kind of synthetic method of anti-tumor drug Rui Boxini | |
CN106046067A (en) | Synthetic method for 1,2-di-O-isopropylidene-3,5,6-tri-O-benzyl-D-glucofuranose | |
CN105085267A (en) | Synthetic method for salvianolic acid A | |
CN101003530B (en) | Method for preparing perfluoroalkyl group sulfonyl isoflavone of possessing anticarcinogenesis | |
Jiang et al. | An efficient, scalable approach to hydrolyze flavonoid glucuronides via activation of glycoside bond | |
CN104003968A (en) | Natural product 3-prenyl Iuteolin analogue (I)/(II), preparation method of natural product 3-prenyl Iuteolin analogue (I)/(II), and application of natural product 3-prenyl Iuteolin analogue (I)/(II) | |
CN103965177B (en) | A kind of anti-tumor activity natural product Herba Peperomiae pellucidae element E semisynthesis | |
CN106632393A (en) | Preparation method for antituberculous candidate drug namely PA-824 | |
CN104650160A (en) | Novel synthesis method of capecitabine key intermediate 1,2,3-O-triacetyl-5-deoxy-D-ribose | |
CN102659657B (en) | Method for synthesizing protease inhibitor PF429242 | |
CN105481814B (en) | A kind of synthetic method of Isorhamnetin | |
CN104974135B (en) | Targeting DNA has the Sai-Mi-Xi-Bu derivative containing benzene-naphthalene diimide structure of antitumor activity, pharmaceutical composition and its preparation method and application | |
CN104130297A (en) | Method for synthesizing capecitabine key intermediate by using high-efficiency dehydrating agent | |
CN102964310A (en) | Preparation method of 2-position substituted imidazole | |
CN102757425B (en) | Novel lipoic octanoylhydrazide derivative, preparation method and application thereof | |
CN113201039B (en) | Preparation method of medical intermediate 2',3',5' -triacetyl azacitidine | |
CN107216360A (en) | A kind of method for preparing rope Citropten | |
WO2023103306A1 (en) | Method for preparing deuterated cytidine derivative |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20160713 Termination date: 20211118 |